Search results for "EOs"

showing 10 items of 2714 documents

The Impact of Amino Acids on Postprandial Glucose and Insulin Kinetics in Humans

2020

Different amino acids (AAs) may exert distinct effects on postprandial glucose and insulin concentrations. A quantitative comparison of the effects of AAs on glucose and insulin kinetics in humans is currently lacking. PubMed was queried to identify intervention studies reporting glucose and insulin concentrations after acute ingestion and/or intravenous infusion of AAs in healthy adults and those living with obesity and/or type 2 diabetes (T2DM). The systematic literature search identified 55 studies that examined the effects of l-leucine, l-isoleucine, l-alanine, l-glutamine, l-arginine, l-lysine, glycine, l-proline, l-phenylalanine, l-glutamate, branched-chain AAs (i.e., l-leucine, l-iso…

Blood GlucoseMaleinsulin secretionobesitymedicine.medical_treatmentAdministration OralReviewType 2 diabetes0302 clinical medicinesystematic reviewInsulinIngestionGlucose homeostasis030212 general & internal medicineInfusions IntravenousNutrition and DieteticsL-ARGININEINTRAVENOUS ARGININEFREE FATTY-ACIDSBLOOD-GLUCOSEdynamicsPostprandial PeriodPostprandialSECRETIONFemaletype 2 diabetesLeucineGROWTH-HORMONElcsh:Nutrition. Foods and food supplyAdultORAL ALANINEmedicine.medical_specialtyMETABOLIC-RESPONSElcsh:TX341-641030209 endocrinology & metabolism03 medical and health sciencesInternal medicinemedicineHumansglucose homeostasisinsulin sensitivityamino acidsbusiness.industryInsulinmedicine.diseaseObesityGlucoseEndocrinologyDiabetes Mellitus Type 2kineticsPLASMA-GLUCAGON RESPONSEtime series dataIsoleucinebusinessFood ScienceINGESTIONNutrients
researchProduct

Cellular ionic alterations with age: relation to hypertension and diabetes.

2000

BACKGROUND: Cytosolic free calcium (Cai) and magnesium (Mgi) are vital to cellular homeostasis and function. OBJECTIVE: To evaluate cellular divalent cations in normal subjects at different ages and their relationship to ion levels in essential hypertension and diabetes. DESIGN: A cross-sectional study. SETTING: A university hospital in New York. PARTICIPANTS: A total of 103 subjects (32 older, 71.1 ± 1.2 y/o, and 71 young/middle aged subjects, 51.1 ± 2.3 y/o). INTERVENTION: Oral glucose tolerance test. MEASUREMENTS: 19F and 31P NMR spectroscopy were used to measure Cai and Mgi levels in erythrocytes from normal (>65 y/o, n = 11; 65 y/o, n = 9; 65 y/o, n = 12; <65 y/o, n = 15) subjects; the…

Blood GlucoseMalemedicine.medical_specialtyAgingErythrocytesMagnetic Resonance Spectroscopymedicine.medical_treatmentCellular homeostasisEssential hypertensionCytosolInternal medicineDiabetes mellitusmedicineHumansInsulinMagnesiumMagnesium ionAgedAged 80 and overGlucose tolerance testmedicine.diagnostic_testbusiness.industryInsulinAge FactorsGlucose Tolerance TestMiddle Agedmedicine.diseaseCausalityEndocrinologyGlycemic indexBlood pressureCross-Sectional StudiesDiabetes Mellitus Type 2Case-Control StudiesHypertensionCalciumFemaleGeriatrics and GerontologybusinessJournal of the American Geriatrics Society
researchProduct

Insulin resistance and atrial fibrillation (from the Framingham Heart Study)

2011

Diabetes mellitus and obesity are increasing in prevalence and are associated with an elevated risk of atrial fibrillation (AF). Given the aging of the United States population, AF is projected to concomitantly increase in prevalence in the upcoming decades. Both diabetes and obesity are associated with insulin resistance. Whether insulin resistance is an intermediate step for the development of AF is uncertain. We hypothesized that insulin resistance is associated with an increased risk of incident AF. We examined the association of insulin resistance with incident AF using multivariate Cox proportional hazards regression analysis adjusting for the established AF risk factors (i.e., age, g…

Blood GlucoseMalemedicine.medical_specialtyPopulationArticleDISEASEBody Mass IndexFramingham Heart StudyInsulin resistanceRisk FactorsInternal medicineDiabetes mellitusAtrial FibrillationConfidence IntervalsMedicineHumansInsulinCOHORTeducationAgedProportional Hazards ModelsRetrospective StudiesMETABOLIC SYNDROMERISKeducation.field_of_studyFramingham Risk Scorebusiness.industryIncidenceHazard ratioDIABETES-MELLITUSMENASSOCIATIONmedicine.diseaseMassachusettsATHEROSCLEROSISHomeostatic model assessmentCardiologyFemaleMetabolic syndromeInsulin ResistanceCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesAmerican Journal of Cardiology
researchProduct

One-hour post-load plasma glucose level is associated with a worse metabolic profile in children with GH deficiency

2017

Purpose: In children, the plasma glucose value at 1 h (1hPG) during OGTT higher than 132.5 mg/dl is a predictor of alterations in glucose metabolism. We aimed to metabolically characterize GHD children according to 1hPG levels. Methods: Fifty-one GHD children (35 M, 16 F; mean age 8.6 years), grouped according to 1hPG, were evaluated at diagnosis and after 12 months of GH treatment (GHT) and compared with 50 matched controls at baseline. Auxological parameters, insulin-like growth factor-1 (IGF-1), glucose and insulin during OGTT, lipid profile, the oral disposition index (DIo), the homeostasis model assessment estimate of insulin resistance (Homa-IR), and the insulin sensitivity index (ISI…

Blood GlucoseMalemedicine.medical_specialtyTime FactorsTime FactorEndocrinology Diabetes and Metabolismmedicine.medical_treatment030209 endocrinology & metabolism030204 cardiovascular system & hematologyCarbohydrate metabolismSettore MED/13 - Endocrinologia03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyInsulin resistanceGH treatmentInternal medicineInsulin SecretionHumansInsulinMedicineChildDwarfism PituitaryGrowth hormoneGlucose tolerance testmedicine.diagnostic_testHuman Growth Hormonebusiness.industryCholesterolInsulinCase-control studynutritional and metabolic diseasesGlucose Tolerance TestInsulin sensitivitymedicine.diseaseMetabolismEndocrinologychemistryCase-Control StudiesChild PreschoolMetabolomeFemaleInsulin ResistanceCase-Control StudiebusinessLipid profileHomeostasisHumanJournal of Endocrinological Investigation
researchProduct

Phenotyping of type 2 diabetes mellitus at onset on the basis of fasting incretin tone: Results of a two-step cluster analysis.

2015

Aims/Introduction According to some authors, in type 2 diabetes there is a reduced postprandial action of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). However, little is known about the role of fasting incretins in glucose homeostasis. Our aim was to evaluate, through a two-step cluster analysis, the possibility of phenotyping patients with type 2 diabetes at onset on the basis of fasting GLP-1, GIP and ghrelin. Materials and Methods A total of 96 patients with type 2 diabetes within 6 months of onset (mean age 62.40 ± 6.36 years) were cross-sectionally studied. Clinical, anthropometric and metabolic parameters were evaluated. At fasting the follow…

Blood GlucoseMalemedicine.medical_treatmentEndocrinology Diabetes and MetabolismSettore MED/13 - Endocrinologiachemistry.chemical_compound0302 clinical medicineGlucagon-Like Peptide 1Glucose homeostasisCluster AnalysisHomeostasis030212 general & internal medicineGeneral MedicineArticlesMiddle AgedGlucagon-like peptide-1GhrelinGlucagon‐like peptide‐1PhenotypeClinical Science and CareFemaleOriginal Articlehormones hormone substitutes and hormone antagonistsGlucagon-like peptide-1medicine.medical_specialtyGlucose-dependent insulinotropic polypeptideIncretin030209 endocrinology & metabolismGastric Inhibitory PolypeptideGhrelin; Glucagon-like peptide-1; Glucose-dependent insulinotropic polypeptide; Endocrinology Diabetes and Metabolism; Internal MedicineIncretins03 medical and health sciencesInsulin resistanceGlucose‐dependent insulinotropic polypeptideInternal medicineDiabetes mellitusmedicineInternal MedicineHumansAgedAdiponectinbusiness.industryInsulinmedicine.diseaseEndocrinologyGlucosechemistryDiabetes Mellitus Type 2Glycated hemoglobinInsulin ResistancebusinessJournal of diabetes investigation
researchProduct

Effects of red wine polyphenols and alcohol on glucose metabolism and the lipid profile: a randomized clinical trial.

2013

Summary Background & aims Epidemiological data suggest that moderate red wine consumption reduces cardiovascular mortality and the incidence of diabetes. However, whether these effects are due to ethanol or to non-alcoholic components of red wine still remains unknown. The aim of the present study was to compare the effects of moderate consumption of red wine, dealcoholized red wine, and gin on glucose metabolism and the lipid profile. Methods Sixty-seven men at high cardiovascular risk were randomized in a crossover trial. After a run-in period, all received each of red wine (30 g alcohol/d), the equivalent amount of dealcoholized red wine, and gin (30 g alcohol/d) for 4 week periods, in a…

Blood GlucoseMalemedicine.medical_treatmentWineCarbohydrate metabolismCritical Care and Intensive Care Medicinechemistry.chemical_compoundInsulin resistanceFolic AcidAdipokinesRisk FactorsDiabetes mellitusmedicineHomeostasisHumansInsulinFood scienceHomocysteineTriglyceridesAgedWineNutrition and DieteticsCross-Over Studiesmedicine.diagnostic_testEthanolCholesterolbusiness.industryInsulindigestive oral and skin physiologyfood and beveragesPolyphenolsFastingMiddle Agedmedicine.diseaseDietVitamin B 12ApolipoproteinsCholesterolGlucosechemistryCardiovascular DiseasesInsulin ResistancebusinessLipid profileLipoproteinClinical nutrition (Edinburgh, Scotland)
researchProduct

The neuropeptide 26RFa (QRFP) is a key regulator of glucose homeostasis and its activity is markedly altered in obese/hyperglycemic mice

2019

International audience; Recent studies have shown that the hypothalamic neuropeptide 26RFa regulates glucose homeostasis by acting as an incretin, and increasing insulin sensitivity. In this study, we further characterized the role of the 26RFa/GPR103 peptidergic system in the global regulation of glucose homeostasis using a 26RFa receptor antagonist, and also assessed whether a dysfunction of the 26RFa/GPR103 system occurs in obese hyperglycemic mice. Firstly, we demonstrate that administration of the GPR103 antagonist reduces the global glucose-induced incretin effect and insulin sensitivity whereas, conversely, administration of exogenous 26RFa attenuates glucose-induced hyperglycemia. U…

Blood GlucoseMaleobesityPhysiologyEndocrinology Diabetes and Metabolism[SDV]Life Sciences [q-bio]RegulatorMice Obese26RFaMice0302 clinical medicineGlucose homeostasisHomeostasisInsulinglucoseComputingMilieux_MISCELLANEOUSCells Cultured0303 health sciencesdiabetesChemistryincretin[SDV] Life Sciences [q-bio]obésitéAlimentation et NutritionCarbohydrate Metabolismdiabètemedicine.medical_specialtyNeuropeptideIncretin030209 endocrinology & metabolism03 medical and health sciencesPhysiology (medical)Diabetes mellitusInternal medicinemedicineAnimalsHumansglucose homeostasisFood and Nutrition030304 developmental biologyhoméostasieNeuropeptidesIncreasing insulinQRFPNeurosciencesGlucose Tolerance Testmedicine.diseaseMice Inbred C57BLEndocrinologyHyperglycemiaNeurons and Cognitionincretin;glucose homeostasis;26RFa;diabetes;obesity
researchProduct

Cardiorespiratory Fitness, Physical Activity, and Insulin Resistance in Children

2020

Purpose Few studies have investigated the independent and joint associations of cardiorespiratory fitness (CRF) and body fat percentage (BF%) with insulin resistance in children. We investigated the independent and combined associations of CRF and BF% with fasting glycemia and insulin resistance and their interactions with physical activity (PA) and sedentary time among 452 children age 6 to 8 yr. Methods We assessed CRF with a maximal cycle ergometer exercise test and used allometrically scaled maximal power output (Wmax) for lean body mass (LM) and body mass (BM) as measures of CRF. The BF% and LM were measured by dual-energy X-ray absorptiometry, fasting glycemia by fasting plasma glucos…

Blood GlucoseMaleobesitymedicine.medical_treatmentliikuntaBody fat percentage0302 clinical medicineHeart RateBody Fat DistributionHomeostasisInsulinOrthopedics and Sports MedicineChildyouthdiabetesexerciseCardiorespiratory FitnessHomeostatic model assessmentFemaleperformancefyysinen aktiivisuusinsulinmedicine.medical_specialtylapset (ikäryhmät)Physical Therapy Sports Therapy and RehabilitationArticle03 medical and health sciencesInsulin resistanceInternal medicineDiabetes mellitusmedicineinsulin sensitivityHumansExercisekehonkoostumusbusiness.industryInsulinCardiometabolic Risk FactorsCardiorespiratory fitness030229 sport sciencesinsuliiniresistenssimedicine.diseaseObesityEndocrinologyLean body massExercise TestInsulin ResistanceSedentary BehaviorbusinessEnergy Metabolism
researchProduct

Impact on Glucose Homeostasis: Is Food Biofortified with Molybdenum a Workable Solution? A Two-Arm Study

2022

Diabetes is expected to increase up to 700 million people worldwide with type 2 diabetes being the most frequent. The use of nutritional interventions is one of the most natural approaches for managing the disease. Minerals are of paramount importance in order to preserve and obtain good health and among them molybdenum is an essential component. There are no studies about the consumption of biofortified food with molybdenum on glucose homeostasis but recent studies in humans suggest that molybdenum could exert hypoglycemic effects. The present study aims to assess if consumption of lettuce biofortified with molybdenum influences glucose homeostasis and whether the effects would be due to c…

Blood GlucoseMolybdenumGIPMineralsNutrition and DieteticsPYYdigestive oral and skin physiologyHuman healthGastric Inhibitory PolypeptideLettucebiofortification; lettuce; human heath; minerals; gut peptides; GIP; PYYGlucoseDiabetes Mellitus Type 2Glucagon-Like Peptide 1Food FortifiedGlucagon-Like Peptide 2Gut peptidesHomeostasisHumansInsulinPeptide YYInsulin ResistanceBiofortificationhormones hormone substitutes and hormone antagonistsFood ScienceNutrients; Volume 14; Issue 7; Pages: 1351
researchProduct

Natural products for the treatment of Type 2 Diabetes Mellitus

2015

Type 2 diabetes mellitus is a metabolic disease characterized by persistent hyperglycemia. High blood sugar can produce long-term complications such as cardiovascular and renal disorders, retinopathy, and poor blood flow. Its development can be prevented or delayed in people with impaired glucose tolerance by implementing lifestyle changes or the use of therapeutic agents. Some of these drugs have been obtained from plants or have a microbial origin, such as galegine isolated from Galega officinalis, which has a great similarity to the antidiabetic drug metformin. Picnogenol, acarbose, miglitol, and voglibose are other antidiabetic products of natural origin. This review compiles the princi…

Blood GlucosePeroxisome Proliferator-Activated ReceptorsPharmaceutical ScienceMedical PlantsPharmacologyAnalytical ChemistryDrug DiscoveryGlucose homeostasisAcarboseClinical Trials as Topicdiabetesbiologyfood and beverages//purl.org/becyt/ford/3.1 [https]Medicina BásicaMolecular Medicine//purl.org/becyt/ford/3 [https]medicine.drugFarmacología y Farmaciamedicine.medical_specialtyCIENCIAS MÉDICAS Y DE LA SALUDBlood sugarfoodInternal medicineYerba-mateVoglibosemedicineDiabetes MellitusHumansHypoglycemic AgentsGlycoside Hydrolase InhibitorsClinical TrialsPharmacologyBiological Productsclinical trialsPlants Medicinalantidiabeticbusiness.industryMiglitolOrganic ChemistryType 2 Diabetes Mellitusalpha-Glucosidasesbiology.organism_classificationfood.foodEndocrinologyDiabetes Mellitus Type 2Complementary and alternative medicineAntidiabeticHyperglycemiaCiencias MédicasGalega officinalisalpha-Amylasesbusinessmedicinal plants
researchProduct